flecainide has been researched along with Left Ventricular Dysfunction in 9 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with heart failure and left bundle branch block (LBBB) are frequently treated with biventricular pacing (BiVP)." | 1.40 | Electrophysiological and hemodynamic effects of vernakalant and flecainide during cardiac resynchronization in dyssynchronous canine hearts. ( Auricchio, A; Houthuizen, P; Kuiper, M; Maessen, JG; Prinzen, FW; Strik, M; van Middendorp, LB, 2014) |
| "Left bundle branch block was induced in 12 canines." | 1.40 | Electrophysiological and haemodynamic effects of vernakalant and flecainide in dyssynchronous canine hearts. ( Auricchio, A; Houthuizen, P; Kuiper, M; Maessen, JG; Prinzen, FW; Strik, M; van Middendorp, LB, 2014) |
| "Average follow up at first AF recurrence was 18." | 1.31 | Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. ( Bacchi Reggiani, L; Bartolotti, M; Biffi, M; Boriani, G; Branzi, A; Zannoli, R, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khalid, U | 1 |
| Rojas, F | 1 |
| Lakkis, N | 1 |
| Hemmeryckx, B | 1 |
| Feng, Y | 1 |
| Frederix, L | 1 |
| Lox, M | 1 |
| Trenson, S | 1 |
| Vreeken, R | 1 |
| Lu, HR | 1 |
| Gallacher, D | 1 |
| Ni, Y | 1 |
| Lijnen, HR | 1 |
| Suzuki, S | 1 |
| Hokosaki, T | 1 |
| Iwamoto, M | 1 |
| van Middendorp, LB | 2 |
| Strik, M | 2 |
| Houthuizen, P | 2 |
| Kuiper, M | 2 |
| Maessen, JG | 2 |
| Auricchio, A | 2 |
| Prinzen, FW | 2 |
| Tsai, WC | 1 |
| Lu, YY | 1 |
| Chen, YC | 1 |
| Chang, CJ | 1 |
| Kao, YH | 1 |
| Lin, YK | 1 |
| Chen, YH | 1 |
| Chen, SA | 1 |
| Yang, LY | 1 |
| Chen, YJ | 1 |
| Kowey, PR | 1 |
| Yan, GX | 1 |
| Winkel, E | 1 |
| Kao, W | 1 |
| Eckardt, L | 1 |
| Haverkamp, W | 1 |
| Göttker, U | 1 |
| Madeja, M | 1 |
| Johna, R | 1 |
| Borggrefe, M | 1 |
| Breithardt, G | 1 |
| Biffi, M | 1 |
| Boriani, G | 1 |
| Bartolotti, M | 1 |
| Bacchi Reggiani, L | 1 |
| Zannoli, R | 1 |
| Branzi, A | 1 |
1 review available for flecainide and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Pharmacologic and nonpharmacologic options to maintain sinus rhythm: guideline-based and new approaches.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Catheter Ablati | 2003 |
8 other studies available for flecainide and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Flecainide-Induced Left Ventricular Dysfunction: Fact or Fiction?
Topics: Aged; Anti-Arrhythmia Agents; Echocardiography, Doppler; Electrocardiography, Ambulatory; Female; Fl | 2017 |
Evaluation of cardiac arrhythmic risks using a rabbit model of left ventricular systolic dysfunction.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Electrocardiography; Flecainide; Magnetic Res | 2018 |
Pharmacologic therapy with flecainide for asymptomatic Wolff-Parkinson-White syndrome in an infant with severe left ventricular dyssynchrony.
Topics: Anti-Arrhythmia Agents; Echocardiography; Electrocardiography, Ambulatory; Flecainide; Heart Ventric | 2018 |
Electrophysiological and hemodynamic effects of vernakalant and flecainide during cardiac resynchronization in dyssynchronous canine hearts.
Topics: Animals; Anisoles; Anti-Arrhythmia Agents; Blood Pressure; Bundle-Branch Block; Cardiac Pacing, Arti | 2014 |
Electrophysiological and haemodynamic effects of vernakalant and flecainide in dyssynchronous canine hearts.
Topics: Action Potentials; Animals; Anisoles; Anti-Arrhythmia Agents; Blood Pressure; Bundle-Branch Block; C | 2014 |
Ablation of androgen receptor gene triggers right ventricular outflow tract ventricular tachycardia.
Topics: Action Potentials; Adenosine; Animals; Caffeine; Calcium; Flecainide; Gene Knockdown Techniques; Gen | 2015 |
Divergent effect of acute ventricular dilatation on the electrophysiologic characteristics of d,l-sotalol and flecainide in the isolated rabbit heart.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Dilatation, Pathologic; Electrocardiography; Fle | 1998 |
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Electro | 2002 |